主な論文
Mishima E et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor.
Nature 2022;608:778-783
Mishima E et al. Recommendations for robust and reproducible research on ferroptosis.
Nat Rev Mol Cell Biol 2025;26:615-630
Ito J, Mishima E, Conrad M et al. PRDX6 dictates ferroptosis sensitivity by directing cellular selenium utilization.
Mol Cell 2024;84:4629-4644
Mishima E et al. DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition.
Nature 2023;619:E9-E18
Mishima E et al. Diverse biological functions of vitamin K: from coagulation to ferroptosis.
Nat Metab 2023;5:924-932
Mishima E and Conrad M. Nutritional and Metabolic Control of Ferroptosis.
Annu Rev Nutr 2022;42:275
Mishima E et al. Drugs Repurposed as Antiferroptosis Agents Suppress Organ Damage, Including AKI, by Functioning as Lipid Peroxyl Radical Scavengers.
J Am Soc Nephrol. 2020;31:280-296